Latest return on equity
Axsome Therapeutics Return on equity
Direct answer
Axsome Therapeutics's return on equity is -245.1%.
The verified market snapshot reports -245.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 17, 2026.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -245.1%
Explore related company data
View Axsome Therapeutics's market capitalizationView Axsome Therapeutics's price-to-book ratioView Axsome Therapeutics's 52-week price rangeView Axsome Therapeutics's revenue growthView Axsome Therapeutics's profit marginView Axsome Therapeutics's debt-to-equity ratioView all Axsome Therapeutics key metricsReturn to Axsome Therapeutics profile